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ABSTRACT
Context: Several Polygonum species (Polygonaceae) are used in traditional medicine in Asia, Europe and
Africa to treat inflammation and diabetes.
Objective: Evaluate the in vitro antioxidant, anti-inflammatory and antidiabetic potential of methanol and
dichloromethane extracts of leaves and roots of the halophyte Polygonum maritimum L.
Material and methods: Antioxidant activity was determined (up to 1mg/mL) as radical-scavenging activ-
ity (RSA) of 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,20-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)
(ABTS), copper (CCA) and iron (ICA) chelating activities and iron reducing power (FRAP). NO production
was measured in lipopolysaccharide (LPS)-stimulated macrophages for 24h at concentrations up to
100lg/mL and antidiabetic potential was assessed by a-amylase and a-glucosidase inhibition (up to
10mg/mL) assays. The phytochemical composition of the extracts was determined by gas chromatog-
raphy-mass spectrometry (GC-MS).
Results: The methanol leaf extract had the highest activity against DPPH· (IC50 ¼ 26lg/mL) and ABTS1·
(IC50 ¼ 140lg/mL), FRAP (IC50 ¼ 48lg/mL) and CCA (IC50 ¼ 770lg/mL). Only the dichloromethane leaf
extract (LDCM) showed anti-inflammatory activity (IC50 ¼ 48lg/mL). The methanol root (IC50 ¼ 19lg/mL)
and leaf (IC50 ¼ 29lg/mL) extracts strongly inhibited baker’s yeast a-glucosidase, but LDCM had higher
rat’s a-glucosidase inhibition (IC50 ¼ 2527lg/mL) than acarbose (IC50 ¼ 4638lg/mL). GC-MS analysis iden-
tified b-sitosterol, stigmasterol, 1-octacosanol and linolenic acid as possible molecules responsible for the
observed bioactivities.
Conclusions: Our findings suggest P. maritimum as a source of high-value health promoting commodities
for alleviating symptoms associated with oxidative and inflammatory diseases, including diabetes.
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Introduction
The genus Polygonum (Polygonaceae) includes more than 200 spe-
cies worldwide, mainly in areas of temperate climate. Several
Polygonum species are used in traditional medicine in China and
Japan to treat health disorders such as dysentery, articular pain and
inflammation (Takasaki et al. 2001; Kawai et al. 2006; Fan et al.
2011). Some species are also used in traditional medicine in
Europe, Africa and Asia to treat diabetes (Soumyanath 2005;
Bothon et al. 2013). In Europe, approximately 36 species of
Polygonum can be found, including P. maritimum L., commonly
known as sea knotgrass. Sea knotgrass is a perennial halophyte
herb native from the sandy coasts of Europe, Mediterranean and
Black Sea, Channel Islands, England and Belgium, occurring fre-
quently throughout the Portuguese coast (Kilinc & Karaer 1995;
Cac¸ador et al. 2013). Polygonum maritimum has described antioxi-
dant and antimicrobial activities (El-Haci et al. 2013), and contains
bioactive molecules such as polygonocinol, (þ)-8-hydroxycala-
mene, octacosyl, triacontyl ferulate, arylpropane, quercetin, querci-
trin, (þ)-catechin, and sitosterol (Kazantzoglou et al. 2009).
Diabetes is an emerging health problem in western societies
affecting more than 300 million people worldwide and is
expected to be the 7th cause of death by 2030 (Mathers & Loncar
2006; Danaei et al. 2011). Type 2 diabetes mellitus (T2DM) is
mainly associated with genetics and lifestyle and encompasses
more than 90% of all diabetes cases globally (Mozaffarian et al.
2009). The major characteristic of T2DM is high blood glucose
level, which is caused by congenital or acquired deficiency in
secretion of insulin combined with decreased responsiveness to
this hormone (WHO 1999; Yarchoan & Arnold 2014). The inhib-
ition of carbohydrate-hydrolyzing enzymes, namely a-amylase and
a-glucosidase, is thus an important strategy to manage hypergly-
caemia linked to T2DM by decreasing the postprandial raise in
blood glucose levels (Kwon et al. 2007). Acarbose, miglitol and
voglibose are clinically used compounds that target a-amylase and
a-glucosidase; however, they present several side effects such as
abdominal distension, flatulence and meteorism (Bischoff &
Flower 1985). In this sense, there has been a growing effort to
search for novel natural compounds with antidiabetic properties
and reduced side effects (Kwon et al. 2007).
Hyperglycaemia found in T2DM patients may also induce
metabolic disturbances leading to the development of
oxidative stress and chronic inflammation states that contribute
to diabetes-associated complications, namely, cardiovascular,
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urological, neurological, kidney and eyes disorders (American
Diabetes Association 2010; Vikram et al. 2014). Oxidative stress
coupled with reduced antioxidant defences enhances damage
caused by free radicals, such as reactive oxygen species (ROS),
and contributes to disease progression (Sabu & Kuttan 2002;
Maritim et al. 2003). In this context, natural antioxidants can be
useful in the prevention and/or management of oxidative stress-
related disorders, including diabetes (Ruhe & McDonald 2001;
Fardoun 2007). ROS also contributes to the production of pro-
inflammatory cytokines and chemokines and to insulin resistance
(Akash et al. 2013; Muriach et al. 2014). The role of oxidative
stress and chronic inflammation in the progression of T2DM
thus opens new avenues in the search for novel and combined
therapies comprising the prevention of oxidative and inflamma-
tory states (Akash et al. 2013).
As stated before, several Polygonum species are used in trad-
itional medicine to treat inflammation and diabetes. However, to
the best of our knowledge, there is no information regarding the
anti-inflammatory and/or antidiabetic potential of the sea knot-
grass. In this context, we report for the first time a comparative
evaluation of the antioxidant and anti-inflammatory potential
and inhibitory activity on key enzymes relevant for hypergly-
caemia (a-amylase and a-glucosidase) of extracts of sea knotgrass
leaves and roots. The phytochemical characterization of the
extracts is also presented.
Material and methods
Chemicals, culture media and supplements
Sigma-Aldrich (Germany) supplied the 1,1-diphenyl-2-picrylhy-
drazyl (DPPH), 2,20-azino-bis(3-ethylbenzothiazoline-6-sulphonic
acid (ABTS) radicals, sodium nitrite, lipopolysaccharide (LPS)
from Escherichia coli, sulfanilamide, N-(1-Naphthyl) ethylenedi-
amine dihydrochloride (NED) and 3-(4,5-dimethylthiazol-2-
yl)2,5-diphenyl tetrazolium bromide (MTT). Folin-Ciocalteau
(F-C) phenol reagent and phosphoric acid were purchased from
Merck (Germany). Lonza (Belgium) provided Roswell Park
Memorial Institute (RMPI) 1640 medium, fetal bovine serum
(FBS), L-glutamine and penicillin/streptomycin. Additional chem-
icals were acquired from VWR International (Belgium).
Sample collection
Whole plants of P. maritimum were hand collected in Ludo,
South of Portugal, in June 2013. The taxonomical classification
was performed by the botanist Dr. Manuel J. Pinto from the
National Museum of Natural History (University of Lisbon,
Botanical Garden, Portugal) and a voucher specimen is kept in
the herbarium of MarBiotech laboratory (MBH22). Plants were
divided in roots and leaves, washed, oven dried for 3 days at
50 C, powdered and stored at 20 C.
Preparation of the extracts
Dried samples were separately extracted with methanol and
dichloromethane (1:40, w/v), overnight at room temperature
(RT), under stirring. The extracts were filtered (Whatman no. 4),
and evaporated to dryness at 40 C in a rotary evaporator under
reduced pressure (BUCHI R-210, Flawil, Switzerland). The dried
extracts were dissolved in the corresponding solvent at the con-
centration of 10mg/mL to be used in the chemical characteriza-
tion assays, or in dimethyl sulfoxide (DMSO) to be used in the
bioactivity assays. All samples were stored at 20 C until
needed.
Gas chromatography and mass spectrometry (GC-MS)
phytochemical analysis
The extracts (100 lL) were filtered (0.2 lm polytetrafluoroethyl-
ene membrane syringe filters), transferred to a glass vial and the
solvent evaporated under a nitrogen stream. When dried, 50 lL
of the derivatization reagent [N-methyl-N-(trimethylsilyl) tri-
fluoroacetamide; MSTFA] was added. With the vial capped, the
extracts were vortexed and heated for 20min in a dry block
heater at 40 C (Pereira et al. 2012).
The GC/MS analyses were performed on an Agilent 6890 ser-
ies gas chromatograph equipped with an Agilent 7683 automatic
liquid sampler coupled to an Agilent 5973N mass selective
detector (Agilent Technologies, Little Falls, DE). A programed
temperature vaporization injector with a septumless sampling
head (Gerstel, Mullheim a/d Ruhr, Germany) and a baffled liner
was used, operating in the solvent vent mode with compressed
air for inlet cooling. Large volume injection was performed
(vent time, 0.30min; flow, 50mL/min; pressure, 0 psi; purge,
60mL/min at 2min), for which the inlet temperature was pro-
gramed from 60 C (0.4min) to 300 C (3min isothermal) at a
rate of 60 C/min and subsequently decreased to 200 C (held
until end) at a rate of 50 C/min. The injection volume and speed
were set at 10 lL and 100lL/min, respectively. GC analysis was
performed on a Zebron ZB-5 (30m 0.25mm I.D., 0.25lm df;
Phenomenex, USA) capillary column (5% phenyl, 95% polydime-
thylsiloxane), using helium as carrier gas maintained in a con-
stant inlet pressure mode of 7.81 psi. The oven temperature was
programed from 100 C (1min) at 20 C/min to 250 C, then at
10 C/min to 300 C and hold for 20min. The transfer line, ion
source and quadrupole analyzer temperatures were maintained at
280 C, 230 C and 150 C, respectively and a solvent delay of
4min was selected. In the full-scan mode, electron ionization
mass spectra in the range 35-550Da were recorded at 70 eV with
an ionization current of 34.6 lA. Data recording and instrument
control were performed by MSD ChemStation software
(G1701CA; version C.00.00; Agilent Technologies).
Radical-scavenging activity (RSA) on DPPH
The RSA against DPPH was determined according to the method
described by Custodio et al. (2015). Extracts (22 lL at concentra-
tions ranging from 60 to 1000lg/mL) were mixed with 200lL of
DPPH solution (120 lM, in methanol) in 96-well microplates
and incubated in the dark for 30min (RT). The absorbance was
measured at 517 nm (Biotek Synergy 4) and results presented as
half maximal inhibitory concentration (IC50, lg/mL). Butylated
hydroxytoluene (BHT) was used as a positive control.
RSA on ABTS1
The RSA against ABTS radical was evaluated by the method
described previously (Rodrigues et al. 2015). A stock solution of
ABTSþ (7.4mM) was generated by reacting equal amounts of
ABTS with potassium persulfate (2.6mM) for 16 h in the dark at
RT. The ABTSþ solution was diluted with ethanol to obtain an
absorbance of at least 0.7 at 734 nm (Biotek Synergy 4). Extracts
(10 lL at concentrations from 60 to 1000lg/mL) were mixed in
96-well microplates with 190lL of ABTSþ solution. After 6min
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of incubation the absorbance was measured at 734 nm (Biotek
Synergy 4). Results were expressed IC50 values (lg/mL). BHT
was used as positive control.
RSA on nitric oxide (NO)
The NO scavenging activity was evaluated according to
Rodrigues et al. (2015) on extracts at concentrations between 60
and 1000lg/mL. Samples (50 lL) were mixed with 50 lL of
10mM sodium nitroprusside in phosphate buffer (PBS) and
incubated for 90min at RT. After, 50 lL of Griess reagent (1% of
sulfanilamide and 0.1% of naphthylethylenediamine in 2.5%
HPO3) were added. The absorbance was read at 546 nm, and
results were expressed as IC50 values (lg/mL). Nx-Nitro-L-argin-
ine methyl ester hydrochloride (L-NAME) was used as standard.
Copper (Cu21) chelating activity (CCA)
The CCA was assessed using pyrocatechol violet as described
previously (Rodrigues et al. 2015). The extracts (30 lL) were
applied at concentrations from 60 to 1000lg/mL and mixed with
200lL of 50mM Na acetate buffer (pH 6), 6 lL of pyrocatechol
violet (4mM) in the above buffer and 100 lL of CuSO45H2O
(50 lg/mL, in water). The change in the colour of the solution
was measured at 632 nm using a microplate reader (Biotek
Synergy 4). Results were expressed as IC50 values (lg/mL).
Ethylenediamine tetraacetic acid (EDTA) was used as a positive
control.
Iron (Fe21) chelating activity (ICA)
The ICA chelating activity was determined by measuring the for-
mation of the Fe2þ ferrozine complex (Megıas et al. 2009),
according to Rodrigues et al. (2015). Extracts (30 lL at concen-
trations between 60 and 1000lg/mL) were mixed in 96-well
microplates with 200 lL of dH2O and 30 lL of a FeCl2 solution
(0.1mg/mL in water). After 30min, 12.5 lL of ferrozine solution
(40mM in water) was added. The change in colour was meas-
ured in a microplate reader (Biotek Synergy 4) at 562 nm, and
results were expressed as IC50 values (lg/mL). EDTA was used
as standard.
Ferric reducing antioxidant power (FRAP) assay
The ability of the extracts to reduce Fe3þ was assayed by the
method described by Megıas et al. (2009). Extracts (50 lL) were
tested at concentrations ranging from 60 to 1000lg/mL and
mixed with distilled water (50 lL) and 1% potassium ferricyanide
(50 lL). After an incubation of 20min at 50 C, 50 lL of 10% tri-
chloroacetic acid (w/v) and ferric chloride solution (0.1%, w/v)
were added and absorbance was measured at 700 nm. Increased
absorbance of the reaction mixture indicates increased reducing
power. Antioxidant activity was calculated relatively to the posi-
tive control (BHT; 1000lg/mL), and expressed as IC50 values
(lg/mL).
Cell culture and cell viability
RAW 264.7 macrophages were maintained in RPMI culture
medium supplemented with 10% heat-inactivated FBS, 1% L-glu-
tamine (2mM), and 1% penicillin (50U/mL)/streptomycin
(50 lg/mL), and were maintained at 37 C in humidified
atmosphere with 5% CO2. Exponentially growing cells were
plated in 96-well tissue plates at a concentration of 1 104 cells/
well and incubated for 24 h. Extracts were then applied at differ-
ent concentrations (3 to 100 lg/mL) for 24 h. Control cells were
treated with DMSO at the highest concentration used in test
wells (0.5%), and cell viability was determined by the MTT col-
orimetric assay (Mosmann 1983). Briefly, 2 h prior to the end of
the incubation period 20 lL of MTT (5mg/mL in PBS) were
added to each well and further incubated at 37 C. Then, 150lL
of DMSO was added to each well in order to dissolve the forma-
zan crystals and absorbance was measured at 590 nm (Biotek
Synergy 4).
Measurement of NO production
The NO production was evaluated using RAW 264.7 macrophages
as described by Rodrigues et al. (2014). Cells were plated at
2.5 105 cells/mL in 96-well tissue plates and allowed to adhere
overnight. Afterwards, they were treated with nontoxic concentra-
tions of the extracts, i.e., those that allowed cellular viability higher
than 80%, in serum- and phenol-free culture medium, containing
100 ng/mL of LPS, for 24 h (Nishishiro et al. 2005). NO produc-
tion was assessed using the Griess assay (Miranda et al. 2001). A
calibration curve was prepared with different concentrations of
sodium nitrite (1.5–100 lM). Results were expressed as percentage
(%) of NO production, relative to a control containing DMSO
(0.5%, v/v), and as IC50 values (lg/mL).
a-Amylase inhibitory activity
The a-amylase inhibitory activity was determined by the method
described by Xiao et al. (2006). Samples (40 lL at concentrations
ranging from 1000 to 10,000lg/mL) were mixed in 96-well
microplates with 40 lL of amylase solution (100U/mL in 0.1M
sodium phosphate buffer, pH 7.0) and 40 lL of 0.1% starch solu-
tion (diluted in the previous buffer). After 10min at 37 C, 20 lL
of 1M hydrochloric acid (HCl) and 100lL of iodide solution
(5mM iodine (I2)þ 5mM potassium iodide (KI), in distilled
water) were added and the absorbance was measured at 580 nm.
Results were expressed as IC50 values (lg/mL). Acarbose was
used as the standard at concentrations between 250 and
10,000 lg/mL.
Baker’s yeast a-glucosidase inhibitory activity
Microbial (Saccharomyces cerevisiae) a-glucosidase inhibitory
activity was determined according to the method described by
Custodio et al. (2015). Samples (50 lL at concentrations ranging
from 20 and 1000lg/mL) were mixed with 100lL of enzyme
solution (1.0U/mL, in 0.1M sodium phosphate buffer, pH 7.0),
and incubated for 10min at 25 C. Then, 50 lL of 5mM p-nitro-
phenyl-a-D-glucopyranoside (NGP; diluted in the previous buf-
fer) were added and incubated more 5min at 25 C. The
absorbance was recorded at 405 nm using a microplate reader
(Biotek Synergy 4) and results were expressed as IC50 values
(lg/mL). Acarbose was used as positive control at concentrations
from 250 to 10,000 lg/mL.
Rat’s intestinal a-glucosidase inhibitory activity
Rat’s intestinal acetone powder was used as a crude enzyme
extract as an example of enzyme of mammalian origin
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(Kwon et al. 2007). Rat’s intestinal acetone powder (250mg)
were mixed with 10mL of 0.1M sodium phosphate buffer (pH
7.0) and centrifuged at 5000  g for 20min at 4 C. The super-
natant (100 lL) was mixed with the extracts (50 lL at concentra-
tions between 500 and 10,000 lg/mL), and incubated for 10min
at 25 C. Then, 50 lL of 5mM p-nitrophenyl-a-D-glucopyrano-
side (NGP; diluted in the previous buffer) was added and the
mixture was incubated for 30min at 37 C. The absorbance was
read at 405 nm using a microplate reader (Biotek Synergy 4), and
results were expressed as IC50 values (lg/mL). Acarbose was used
as positive control at concentrations from 250 to 10,000 lg/mL.
Statistical analysis
Results were expressed as mean ± standard error of the mean
(SEM), and experiments were carried out at least in triplicate.
Significant differences were assessed by analysis of variance
(ANOVA) followed by Duncan’s New Multiple Range Test, or by
Kruskal–Wallis test when parametricity of data did not prevail.
SPSS statistical package for Windows (release 15.0, SPSS Inc.)
was used. The IC50 values were calculated by sigmoidal fitting of
the data in the GraphPad Prism v. 5.0 software.
Results
Phytochemical analysis
In order to determine their chemical composition, extracts were
analyzed by GC-MS (Figure 1 and Table 1). This analysis was
able to identify a large number of compounds detected in the
methanol extracts (70–75%). However, a large percentage of
compounds detected in the dichloromethane extracts could not
be identified (45–48%). In total, 51 compounds were identified
belonging to different classes of biochemicals: alkanes and
alkenes (AA), fatty acids (FA), phenolic compounds (PC), acyl-
glycerols (GLY), saccharides (SAC), alcohols (ALC), phytosterols
(PS) and minor groups (MG).
With similar contents, fatty acids (24.3%) and acylglycerols
(22.8%) were the most represented categories in the methanol leaf
extract (LM), in which 2-monostearin (35) was the major com-
pound (15.4%). Palmitic acid (18), linolenic acid (23), 1-monopal-
mitin (34), glycerol (43), and b-sitosterol (47) were also
detected at abundances higher than 5%. Acylglycerols were the
most abundant constituents of the LM extract (34.4%), with 1-
monostearin (31) being the most representative compound
(24.0%), while 1-monopalmitin (34) and oleamide (51)
Figure 1. Main chemical compound classes identified by GC/MS in the dichloromethane and methanol extracts of roots and leaves of P. maritimum. (A) Methanol leaf
extract; (B) Methanol root extract; (C) Dichloromethane leaf extract; and (D) Dichloromethane root extract. AA: alkanes and alkenes; FA: fatty acids; PC: phenolic com-
pounds; GLY: acylglycerols; SAC: saccharides; ALC: alcohols; PS: phytosterols; MG: minor groups; NI: non-identified compounds.
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represented 10.3 and 6.66% of the total identified components,
respectively. In the dichloromethane leaf extract (LDCM), fatty
acids represented 15.7% and phytosterols (PS) 12.0% of the total
identified compounds. b-Sitosterol (47; 10.5%) and 1-octacosanol
(45; 8.7%) were the major components identified. Similarly, the
dichloromethane root extract (RDCM) had the highest content in
phytosterols (PS; 19.0%) and fatty acids (FA; 16.7%), in which
b-sitosterol (47, 19.0%) was the main component, followed by
palmitic acid (18) and 1-monostearin (37) at 6.5 and 5.4%,
respectively.
Antioxidant activity
The P. maritimum LM and methanol root (RM) extracts showed
high RSA for both DPPH and ABTS radicals, coupled with a
Table 1. Phytochemical composition of the methanol and dichloromethane extracts of P. maritimum leaves and roots, determined by GC/MS analysis.
Relative abundance (%)
Methanol Dichloromethane
ID RT (min) Compound Molecular formula Leaves Roots Leaves Roots
Alkanes/Alkenes
1 5.61 2,6,11-Trimethyl dodecane C15H32 0.67
2 5.63 Phytane C20H42 0.22 0.21
3 5.66 2,6,10,15-Tetramethyl heptadecane C17H36 0.72
4 6.75 Tetradecane C14H30 0.97 0.32 0.40
5 8.55 Cetane C16H34 0.16 0.18
6 8.63 2-Methyl octadecane C19H40 0.78 0.26
7 9.78 Octacosane C28H58 0.77 0.37 0.70
8 9.90 3,11-Dimethyl nonacosane C31H64 1.10
9 11.57 Eicosane C20H42 0.90
10 12.39 Docosane C22H46 1.78 1.01
11 12.40 Tricosane C23H48 0.73
12 14.10 Pentacosane C25H52 0.59
13 16.89 1-Nonadecene C19H38 0.87
14 17.75 Nonacosane C29H60 1.80
Fatty acids
15 5.75 Pelargonic acid C12H18O2 0.28 0.17
16 7.72 Lauric acid C12H24O2 1.51 0.25 0.23
17 8.92 Myristic acid C14H28O2 1.22 1.72 0.65
18 10.28 Palmitic acid C16H32O2 6.40 1.46 4.49 6.53
19 11.08 Linoleic acid C18H32O2 1.79 2.32 0.35
20 11.18 Margaric acid C17H34O2 0.14 0.20
21 11.75 Oleic acid C18H34O2 4.13 2.32 3.21
22 11.85 Linolenic acid C18H30O2 0.95
23 11.94 Stearic acid C18H36O2 6.71 4.27 1.83 1.38
24 13.59 Arachidic acid C20H40O2 1.71 1.05
25 15.32 Behenic acid C22H44O2 1.35 2.64
26 17.10 Lignoceric acid C24H48O2 0.53 1.29 1.78
Phenols
27 5.09 Benzoic acid C7H7O2 3.24 0.51
28 6.94 Butylated hydroxytoluene C15H24O 0.99 1.31 0.17 0.27
29 7.12 Vanillin C8H8O3 0.68
30 7.70 Phloroglucinol C6H6O3 0.92
31 9.63 Methyl 3-(3,4-di-tert-butyl-4-
hydroxyphenyl)propionate
C18H28O3 0.68 0.66
32 9.69 Gallic acid C7H6O5 1.15 0.54 1.97
Acylglycerols
33 14.63 2-Monopalmitin C19H38O4 1.28
34 14.89 1-Monopalmitin C19H38O4 5.89 10.3 2.20 3.05
35 16.14 2-Monostearin C19H38O4 15.4 0.34
36 16.27 1-Monoolein C21H40O4 0.35 0.47
37 16.59 1-Monostearin C19H38O4 1.08 24.1 2.87 5.44
Saccharides
38 8.69 D-Fructose C6H7O6 4.40 0.97 0.39 0.27
39 9.02 b-D-Glucofuranose C6H12O6 0.85
40 9.34 b-D-Glucopyranose C6H12O6 1.05 0.14
41 9.41 a-D-Glucopyranose C6H12O6 0.45
Alcohols
42 4.12 Butane-1,3-diol C4H10O2 0.62
43 5.18 Glycerol C3H8O3 5.20 5.02
44 11.35 Phytol C20H40O 0.62
45 20.91 1-Octacosanol C28H58O 8.72
Phytosterols
46 24.51 Stigmasterol C29H48O 1.37
47 25.88 b-Sitosterol C29H50O 5.90 1.88 10.6 19.0
Minor groups
48 5.25 Phosphoric acid H3PO4 0.62 0.55 0.46 0.34
49 7.44 Diethyl phthalate C12H14O4 0.35
50 7.78 Thymine C5H6N2O2 0.46
51 13.11 Oleamide C18H35NO 0.89 6.66 2.30 3.13
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strong capacity for reducing iron and chelating copper (Table 2).
In the DPPH assay, the methanol extracts of both organs had
similar IC50 values (roots: 27 lg/mL; leaves: 26 lg/mL), which
were significantly lower than the one obtained with the positive
control (BHT, 110lg/mL; Table 2). Regarding the ABTS radical,
both the RM and LM extracts had IC50 of 192 and 140lg/mL,
respectively, which were similar to that of BHT (140 lg/mL;
Table 2). The RM and LM had also high ability to reduce iron
with IC50 values of 64 and 48 lg/mL, respectively (Table 2). A
moderate iron reduction was obtained upon addition of the
RDCM (IC50¼ 770 lg/mL) and LDCM (IC50¼ 798 lg/mL)
extracts. However, none of the extracts had the capacity for scav-
enging the NO radical or for chelating iron (Table 2).
Anti-inflammatory activity
To assess the in vitro anti-inflammatory activity, the effect of
applying nontoxic concentrations of the extracts (i.e. yielding cell
viability >80%) on the NO production by LPS-stimulated RAW
264.7 macrophage cells was determined. A significant reduction
in cell viability was observed upon applying the LM extract at a
concentration of 100lg/mL to the cells. Loss of viability was also
observed with the RDCM extract at 50 and 100lg/mL (data not
shown). Therefore, these concentrations were not used in the
anti-inflammatory activity assessment.
Exposure of RAW 264.7 cells to LPS at 100 ng/mL increased
the nitrite concentration in the culture medium from a basal
level of approximately 0.3 lM to around 13 lM (data not shown).
This increase was significantly reduced in a dose-dependent man-
ner by the treatment with LDCM, at concentrations ranging
from 25 to 100 lg/mL, showing that the latter had an activity
similar to the positive control (L-NAME) at the same concentra-
tion (Figure 2). However, this extract had an IC50 value of
48 lg/mL, higher than that of L-NAME (29.1 lg/mL; data not
shown). Interestingly, incubating this cell line with the remaining
extracts resulted in an increase in NO production when com-
pared to the control (Figure 2). In particular, incubation with
LM and RM extracts resulted in the most significant increases in
NO production: 144% at the concentration of 50 lg/mL and
139% at 25 lg/mL, respectively.
Antidiabetic activity
The inhibitory potential of extracts from P. maritimum was eval-
uated against a-amylase and baker’s yeast and rat’s a-glucosi-
dases (Table 3). The methanol extracts had the highest capacity
to inhibit the baker’s yeast a-glucosidase with IC50 values of
19 and 29 lg/mL for roots and leaves, respectively, which were
significantly lower than that of acarbose (IC50¼ 3144lg/mL).
Despite the fact that methanol extracts had no capacity to inhibit
rat’s a-glucosidase, LDCM had the highest rat’s a-glucosidase
inhibitory activity (IC50¼ 2527lg/mL), which was a significantly
lower IC50 value than that of acarbose (4638 lg/mL; p< 0.05).
Discussion
In order to confirm the use of Polygonum species in traditional
medicine in the treatment of inflammation and diabetes, we
assessed for the first time the phytochemical composition of P.
maritimum and its in vitro anti-inflammatory and antidiabetic
potential.
GC-MS analysis detected alkanes, alkenes and fatty acids as
the major categories of compounds in P. maritimum extracts.
These are lipophilic compounds widely distributed in plants
as constituents of plant waxes and have been described in
the halophilic Mediterranean Suaeda vera Forssk. ex J.F.Gmel.
(Amaranthaceae), Sarcocornia fruticosa (L.) A.J.Scott
(Amaranthaceae), and Halimione portulacoides (L.) Aellen
(Amaranthaceae) (Grossi & Raphel 2003). Waxes usually have a
protective role, for example, against microbial infections and
avoiding excessive water losses and acute osmotic stress that
halophilic species suffer while growing in drenched soils (M€uller
& Riederer 2005; Huang et al. 2011). Moreover, they are com-
mon constituents of essential oils of halophyte species, such as
Suaeda fructicosa and Limonium echioides (L.) Mill.
(Plumbaginaceae) (Saïdana et al. 2008). From the compounds
detected in this study, only b-sitosterol (47) had been previously
identified in P. maritimum also in dichloromethane extracts.
Phytol (44), palmitic (18) and lauric (16) acids were also previ-
ously detected as components of essential oils of Polygonum spe-
cies, namely P. hydropiper L. and P. minus Huds. (Miyazawa &
Tamura 2007; Baharum et al. 2010).
Our findings showed that P. maritimum has a strong antioxi-
dant activity comparable to that reported by other authors for
similar extracts made from aerial parts of the same species
(El-Haci et al. 2013) and P. sachalinensis F.Schmidt and P. cuspi-
datum Siebold & Zucc. (Pan et al. 2007; Fan et al. 2011).
Moreover, IC50 values obtained with the RM and LM were sig-
nificantly lower than or similar to the one obtained with the
positive control (BHT) for DPPH and ABTS assays, respectively.
The significantly higher antioxidant activity of these extracts can
be related to the presence of some of the compounds identified
in these extracts, namely, the phenolic compounds benzoic acid,
BHT, vanillin and phloroglucinol, since these compounds are
Table 2. Radical scavenging activity (RSA) on DPPH, ABTS and NO radicals, metal chelating activity on iron (ICA) and copper (CCA)
and ferric reducing activity (FRAP) activity of methanol (MeOH) and dichloromethane (DCM) extracts of roots and leaves of P.
maritimum.
RSA Metal chelation/reduction
Extract/Standard Plant organ DPPH ABTS NO CCA ICA FRAP
MeOH Leaves 26 ± 0.7a 140 ± 6a n.a. 290 ± 10b n.a. 48 ± 1.4a
Roots 27 ± 0.0a 192 ± 5b n.a. 446 ± 8c n.a. 64 ± 3.8a
DCM Leaves n.a. n.a. n.a. n.a. n.a. 798 ± 36b
Roots n.a. n.a. n.a. n.a. n.a. 770 ± 53b
BHT – 110 ± 10b 140 ± 10a – – – –
L-NAME – – – 2500 ± 10 – – –
EDTA – – – – 170 ± 10a 55.9 ± 3.7 –
Results are expressed as IC50 values (lg/mL). Positive control; n.a.: not active. Values are means ± SEM of three separate experiments
performed in triplicate (n¼ 9). In the same column, means labelled with different letters are significantly different by Duncan’s mul-
tiple range test (p< 0.05).
PHARMACEUTICAL BIOLOGY 1353
well described as strong antioxidants in vitro (Foti 2007; Dai &
Mumper 2010). Phytol and linolenic acid have also been
described as potent in vitro and in vivo antioxidants due to their
hydroxyl group (Richard et al. 2008; Santos et al. 2013). Thus,
their presence in the LM could also contribute to the high RSA
and ICA of this extract. Interestingly, no significant differences
were observed between the antioxidant activity of leaves and
roots as opposed to that reported for other halophytes species,
such as Mesembryanthemum edule L. (Aizoaceae), Limoniastrum
monopetalum (L.) Boiss. (Plumbaginaceae), Salsola kali L.
(Chenopodiaceae), Tamarix gallica L. (Tamaricaceae) and
Limonium algarvense Erben (Plumbaginaceae) (Ksouri et al.
2008; Falleh et al. 2012; Trabelsi et al. 2012; Rodrigues et al.
2015). This can be explained by the similar phytochemical profile
of the methanol extracts of both organs (Figure 1 and Table 1),
suggesting that the bioactive compound(s) are not organ-specific.
LPS is a cell wall endotoxin produced by Gram-negative bac-
teria that activates macrophages to produce inflammatory media-
tors such as NO (Martich et al. 1993), a radical associated with
chronic inflammation (Kubes 2000; Joo et al. 2014). In this con-
text, a decrease in NO production is used as an indicator of the
potential for the extracts to reduce an inflammatory response
(Joo et al. 2014; Rodrigues et al. 2014). On the other hand,
an increase in NO production can indicate an immunostimula-
tory effect of the extracts, which is important in macrophage
defence and protection against infection (Wink et al. 2011).
The anti-inflammatory effect of P. maritimum leaves may be
attributed to the presence of compound(s) with potential anti-
inflammatory properties, most likely b-sitosterol, stigmasterol,
1-octacosanol, oleamide as well as linolenic and oleic acids
(Table 1). For instance, b-sitosterol, one of the major constitu-
ents of this extract, has anti-inflammatory properties through
TNF-a inhibition (Loizou et al. 2010), and so do 1-octacosanol
and oleic acid (Vassiliou et al. 2009; de Oliveira et al. 2012). In
turn, linolenic acid and oleamide are able to reduce NO produc-
tion and inducible nitric oxide synthase (iNOS) gene expression,
through the inhibition of the NF-jB pathway (Ren & Chung
2007; Oh et al. 2010). Stigmasterol was also reported to inhibit
the production of pro-inflammatory mediators associated with
the same pathway (Gabay et al. 2010). The combination of all
these compounds in the LDCM of P. maritimum are probably
contributing to its NO inhibitory capacity, since they were solely
identified in this extract, or in higher quantities (Figure 2). These
findings are in accordance with several reports on the anti-
inflammatory properties of Polygonum species (P. lapathifolium
L., P. cuspidatum and P. perfoliatum L. (Takasaki et al. 2001;
Kim et al. 2007; Fan et al. 2011; Lei et al. 2015).
NO has an important role in the immune system modulation,
being one of the macrophage-mediated primary responses against
pathogens such as fungi, helminthes, protozoa and bacteria
(Wink et al. 2011). In this sense, the increased NO production
suggests that both the LM and RM from P. maritimum may have
immunostimulatory properties (Wink et al. 2011) most likely due
to the presence of specific molecules in these extracts, namely,
saturated fatty acids (stearic and palmitic acids), which are
known inducers of the production of pro-inflammatory cytokines
in macrophages (Valdearcos et al. 2012; Miao et al. 2015).
In fact, immunostimulatory properties are reported in
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Figure 2. Effect of the application of dichloromethane and methanol extracts of roots and leaves of P. maritimum on NO production (%) by LPS-stimulated macro-
phages. Control cells were treated with culture medium supplemented with 0.5% DMSO and 100 ng/mL of LPS. L-NAME (positive control) was applied at the concentra-
tion of 100lg/mL. Solid and errors bars represent the average and SEM, respectively (n¼ 9). Bars followed by different letters are significantly different according to
the Duncan’s multiple ranges test (p< 0.05).
Table 3. Inhibitory activity of dichloromethane and methanol extracts of roots
and leaves of P. maritimum on a-amylase, baker’s yeast a -glucosidase and rat’s
intestinal a-glucosidase.
Extract/Standard Organ a-Amylase Yeast a-glucosidase Rat a-glucosidase
Methanol Leaves n.a. 29 ± 0.7a n.a.
Roots n.a. 19 ± 0.5a n.a.
Dichloromethane Leaves n.a. 585 ± 27b 2527 ± 37
Roots n.a. 626 ± 14b >2500
Acarbose 7797 ± 98 3144 ± 132c 4638 ± 438
Results are expressed as IC50 values (lg/mL). Positive control; n.a.: not active.
Values are means ± SEM of three separate experiments performed in triplicate
(n¼ 9). In the same column, means labelled with different letters are signifi-
cantly different by Duncan’s multiple range test (p< 0.05).
1354 M. J. RODRIGUES ET AL.
P. multiflorum, P. minus and P. cuspidatum (Chen et al. 2012;
Veerasamy et al. 2014; Chueh et al. 2015).
Compounds with the capacity to inhibit carbohydrate-
hydrolyzing enzymes like a-amylase and a-glucosidase can delay
the digestion of carbohydrates, decreasing the postprandial
increase of blood glucose level after a mixed carbohydrate meal,
and therefore can be an important strategy in managing hyper-
glycaemia linked to T2DM (Krentz & Bailey 2005; Kwon et al.
2007; Bhandari & Ansari 2008).
It is noteworthy that methanol extracts were approximately
100-fold more active towards baker’s yeast a-glucosidase than
acarbose and that the LDCM had 2-times more ability to inhibit
rat’s a-glucosidase. High IC50 values for acarbose against this
enzyme have also been reported by other authors (4823 lg/mL)
(Gao et al. 2013). However, the methanol extracts had no cap-
acity to inhibit rats a-glucosidase, which is a common feature of
molecules with inhibitory capacity on a-glucosidase from micro-
bial origin (Oki et al. 1999; Shai et al. 2011). Furthermore, a few
in vitro studies have discussed the low capacity of acarbose to
inhibit mammalian a-glucosidase compared to crude extracts,
including aqueous ethanol extracts from P. senegalensis (Meisn.)
Sojak (Polygonaceae), which is used in folk medicine to treat
T2DM (Shinde et al. 2008; Bothon et al. 2013). Those differences
are usually attributed to additive or synergistic interactions of the
compounds present in the extracts, resulting in a higher capacity
to inhibit the mammalian a-glucosidase (Adisakwattana et al.
2012). The higher activity of the LDCM can be related with the
presence of some particular compounds. For example, b-sitos-
terol was the main compound identified in this extract (Table 1)
and was previously reported to possess strong hypoglycaemic
activity through a-glucosidase inhibition (Ortiz-Andrade et al.
2007). The same properties were described for stigmasterol and
linolenic acid, present only in this extract, as well as for oleic
acid (Ortiz-Andrade et al. 2007; Lean Teik et al. 2013; Su et al.
2013). In fact, Su et al. (2013) reported that linolenic and oleic
acids were more active than acarbose. Although none of the
extracts achieved 50% of inhibitory activity in the a-amylase
assay, our data suggest that P. maritimum may have potential as
a source of antidiabetic molecules. This is in accordance with the
antidiabetic activity found in several Polygonum species, such as
P. aviculare L. (Polygonaceae), P. cuspidatum, P. multiflorum and
P. senegalensis (Soumyanath 2005; Bothon et al. 2013).
Conclusions
The present study highlights for the first time the potential of
the halophyte P. maritimum as a source of compounds with anti-
oxidant, anti-inflammatory and antidiabetic activities. The metha-
nol extracts had the highest antioxidant capacity, possibly due to
the presence of benzoic acid, BHT, phloroglucinol, phytol and
linolenic acid. The dichloromethane extracts from P. maritimum
leaves had significant anti-inflammatory activity, most likely
related to its main constituents identified as b-sitosterol, stigmas-
terol, 1-octacosanol, oleamide, linolenic and oleic acids.
Moreover, its high a-glucosidase inhibitory activity may be
related to the presence of b-sitosterol, stigmasterol, linolenic and
oleic acid. Overall, our results indicate that P. maritimum
extracts are endowed with compounds with potential to be used
as a combined strategy to manage T2DM due to its anti-inflam-
matory, antioxidant and a-glucosidase inhibitory properties.
These results could be the starting points to further explore
P. maritimum, especially its leaves, as a source of value-
added bioactive natural products. Nonetheless, isolation and
identification of the molecules(s) responsible for the detected bio-
logical activities is already being pursued.
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